Northwest Biotherapeutics reported $311K in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Agenus USD 22.34M 107K Mar/2026
AstraZeneca USD 18.86B 972M Jun/2026
Bristol-Myers Squibb USD 13.83B 535M Jun/2026
Celldex Therapeutics USD 230K 0 Jun/2026
Eisai JPY 253.13B 26.12B Jun/2026
Merck USD 12.21B 435M Mar/2026
Northwest Biotherapeutics USD 311K 299K Sep/2025
Pfizer USD 16.19B 19M Jun/2026
Plus Therapeutics USD 1.35M 1.03M Mar/2026
Roche Holding CHF 13.34B 1.44B Jun/2026